hit counter
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Stock News Sentiment & Price - Sentifly
BHVN - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

USA
Biotechnology
NYSE
BHVN Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
BHVN Latest news
Zacks Investment Research
Positive
Biohaven (BHVN) Q3 Nurtec Preliminary Sales Top Expectations
2021-10-06 19:20

Biohaven's (BHVN) sole marketable drug, Nurtec ODT reports preliminary sales for the third quarter, which beat expectations.

PRNewsWire
Neutral
Biohaven Announces Preliminary 3Q2021 Net Product Revenue For NURTEC ODT, The First And Only Migraine Medication For Both Acute And Preventive Treatment
2021-10-05 07:30

NEW HAVEN, Conn., Oct. 5, 2021 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd.

Zacks Investment Research
Neutral
Biohaven (BHVN) Phase III Multiple System Atrophy Study Fails
2021-09-28 11:36

Biohaven's (BHVN) myeloperoxidase enzyme inhibitor, verdiperstat fails to statistically differentiate from placebo in improving disease progression in patients with multiple system atrophy in a late-stage study.

Benzinga
Negative
Why Are Biohaven Shares Trading Lower On Monday?
2021-09-27 09:31

Biohaven Pharmaceutical Holding Company Ltd (NYSE: BHVN) has announced results from a focused analysis of verdiperstat trial in verdiperstat in multiple system atrophy (MSA).  Verdiperstat did not differ statistically from placebo on the prespecified primary efficacy measure or the key secondary efficacy measures.

PRNewsWire
Neutral
Biohaven Provides Update On Phase 3 Trial And Multiple System Atrophy (MSA) Program
2021-09-27 07:00

NEW HAVEN, Conn., Sept. 27, 2021 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd.

Zacks Investment Research
Positive
Why Is Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Up 21.7% Since Last Earnings Report?
2021-09-08 13:16

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) reported earnings 30 days ago.

24/7 Wall Street
Neutral
Tuesday Afternoon Analyst Upgrades and Downgrades: SmileDirectClub, Squarespace, Victoria's Secret and More
2021-08-10 12:56

With the trading day more than halfway over, the broad markets were mixed yet again, but this came with a couple of record highs.

Zacks Investment Research
Neutral
Biohaven (BHVN) Q2 Earnings Miss, Nurtec Uptake Still Strong
2021-08-09 13:53

Biohaven's (BHVN) sole approved drug, Nurtec ODT for treating migraine continues to demonstrate strong demand in the United States. Higher operating expense drags down the bottom line.

Seeking Alpha
Neutral
Biohaven Pharmaceutical Holding Company's (BHVN) CEO Vlad Coric on Q2 2021 Results - Earnings Call Transcript
2021-08-09 13:53

Biohaven Pharmaceutical Holding Company's (BHVN) CEO Vlad Coric on Q2 2021 Results - Earnings Call Transcript

Loading more news...